Main content

Anti-Biotic Resistance

Antibiotic resistance is a global problem. No new drugs have been produced since the 1980s. So who is to blame? The public's over-consumption or the economics of Pharma companies?

Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.

GUESTS

Seema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the Nordics

Lord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman Sachs

Professor Colin Garner, Co Founder and Director, Antibiotic Research UK

Available now

24 minutes

Broadcast

The Disrupters

The Disrupters

Unfiltered, revealing interviews with pioneering entrepreneurs.

The Open University

The Open University

Go beyond the headlines and learn more about business with The Open University.

The EU after Brexit

The EU after Brexit

Evan Davis and David Aaronovitch present a programme looking at the EU after Brexit.

Podcast